MedTrace Logo

Wound Fluid Protease Levels During Use of Novel Wound Dressing

NCT01567150 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2016-11-25

Study results available
· View outcomes & findings →

Summary

This study is being conducted to characterize the way leg wounds respond to a new type of wound dressing, compared to wounds in patients who are not using the new dressing. The investigators will collect wound fluid for biochemical analysis, and they will measure the wound healing that occurs with and without the new dressing.

Conditions

  • Venous Stasis Ulcers

Interventions

DEVICE

Novel Dressing

Topical wound dressing

Sponsors & Collaborators

  • Hollister Incorporated

    lead INDUSTRY

Principal Investigators

  • Ginger Salvadalena, PhD, RN · Hollister Incorporated

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01567150 on ClinicalTrials.gov